amifostine anhydrous has been researched along with Carcinogenesis in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cook, JA | 1 |
| Naz, S | 1 |
| Anver, MR | 1 |
| Sowers, AL | 1 |
| Fabre, K | 1 |
| Krishna, MC | 1 |
| Mitchell, JB | 1 |
| Oliai, C | 1 |
| Yang, LX | 1 |
1 review available for amifostine anhydrous and Carcinogenesis
| Article | Year |
|---|---|
Radioprotectants to reduce the risk of radiation-induced carcinogenesis.
Topics: Amifostine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Caloric Restriction; Car | 2014 |
1 other study available for amifostine anhydrous and Carcinogenesis
| Article | Year |
|---|---|
Cancer Incidence in C3H Mice Protected from Lethal Total-Body Radiation after Amifostine.
Topics: Amifostine; Animals; Carcinogenesis; Dose-Response Relationship, Radiation; Female; Mice; Neoplasms, | 2018 |